Corregene Biotechnology Co., Ltd – Trademark Portfolio
Entity Type: 99
Corregene Biotechnology Co., Ltd holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include CR, CORREGENE, CORENGAGER, and CR CORREGENE.
Room 317-2, 3rd Floor, Building 1,
No. 1 Nengyuan East Road, Shahe Town, Ch
Showing of trademarks Trademarks
Trademark Classifications
Corregene Biotechnology Co., Ltd's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Corregene Biotechnology Co., Ltd have?
Corregene Biotechnology Co., Ltd has 7 U.S. trademarks filed with the USPTO. Of these, 7 registered.
What trademark classes does Corregene Biotechnology Co., Ltd file in?
Corregene Biotechnology Co., Ltd files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Corregene Biotechnology Co., Ltd's most well-known trademarks?
Corregene Biotechnology Co., Ltd's registered trademark portfolio includes well-known marks such as CR, CORREGENE, CORENGAGER, and CR CORREGENE. These are among 7 currently registered trademarks in the portfolio.
What is Corregene Biotechnology Co., Ltd's trademark registration success rate?
Corregene Biotechnology Co., Ltd has a 100% trademark registration rate, with 7 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.